RecruitingNot ApplicableNCT07219251

Engagement of Veterans With Lung Cancer

Engagement of Veterans With Lung Cancer (EVLC)

Sponsor

Palo Alto Veterans Institute for Research

Enrollment

194 participants

Start Date

Feb 27, 2026

Study Type

INTERVENTIONAL

Conditions

Lung Adenocarcinoma Lung Cancer (NSCLC)

Summary

This research study will help our understanding of whether additional support for Veterans with lung cancer can improve their quality of life.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is focused on understanding and improving how veterans with lung cancer engage with their own cancer care. Researchers believe that helping patients feel more informed, heard, and involved in their treatment decisions leads to better outcomes. The study will collect information through surveys to identify unmet needs and test new ways to support veterans throughout their lung cancer journey. **You may be eligible if...** - You are a veteran with a diagnosis of lung cancer at any stage - You are 18 or older - You speak English or Spanish - You are receiving cancer care at a participating site - You have been newly diagnosed, are currently receiving treatment, or have completed treatment within the past 12 months **You may NOT be eligible if...** - You do not have the capacity to give informed consent - You are currently receiving hospice or end-of-life care Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALLay Health Worker (LHW) Planning

Patients randomized to the LHW group will receive usual care provided by their oncology (or primary) clinical team along with an initial 30-minute telephone call with the LHW from Palo Alto, followed by weekly 15-minute phone calls (or as needed) for 6months. These calls are designed to assist with healthcare planning, symptom management, and discussions about care preferences and goals.

OTHERUsual Care Group

Participants randomized to the usual care group will receive usual care provided by their oncology clinical team. These teams have been trained in symptom assessment, goals-of-care (GoC) discussions, and documentation of such clinical services. As part of usual care, participants may engage in symptom and GoC discussions at any time, initiated by either the patient or the clinician.